BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32294669)

  • 1. Survival trends of patients with oral and oropharyngeal cancer treated at a cancer center in São Paulo, Brazil.
    Kowalski LP; Oliveira MM; Lopez RVM; Silva DRME; Ikeda MK; Curado MP
    Clinics (Sao Paulo); 2020; 75():e1507. PubMed ID: 32294669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
    Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective cohort study of prognostic factors in patients with oral cavity and oropharyngeal squamous cell carcinoma.
    Carrillo JF; Carrillo LC; Cano A; Ramirez-Ortega MC; Chanona JG; Avilés A; Herrera-Goepfert R; Corona-Rivera J; Ochoa-Carrillo FJ; Oñate-Ocaña LF
    Head Neck; 2016 Apr; 38(4):536-41. PubMed ID: 25351827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Chen MM; Harris JP; Hara W; Sirjani D; Divi V
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1224-1230. PubMed ID: 27832255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: impact on survival.
    Broglie MA; Haerle SK; Huber GF; Haile SR; Stoeckli SJ
    Head Neck; 2013 May; 35(5):660-6. PubMed ID: 22605675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral and oropharyngeal cancer in the West of Scotland-long-term outcome data of a prospective audit 1999-2001.
    McMahon JD; Robertson GA; Liew C; McManners J; Mackenzie FR; Hislop WS; Morley SE; Devine J; Carton AT; Harvey S; Hunter K; Robertson AG
    Br J Oral Maxillofac Surg; 2011 Mar; 49(2):92-8. PubMed ID: 20646803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
    Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
    J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral and oropharyngeal squamous cell carcinoma in young patients: the Netherlands Cancer Institute experience.
    van Monsjou HS; Lopez-Yurda MI; Hauptmann M; van den Brekel MW; Balm AJ; Wreesmann VB
    Head Neck; 2013 Jan; 35(1):94-102. PubMed ID: 22431238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and survival outcomes of lip, oral cavity, and oropharyngeal squamous cell carcinoma in a southeast Brazilian population.
    Louredo BV; Vargas PA; Pérez-de-Oliveira ME; Lopes MA; Kowalski LP; Curado MP
    Med Oral Patol Oral Cir Bucal; 2022 May; 27(3):e274-e284. PubMed ID: 35368013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of time to simulation and treatment for patients with oropharyngeal cancer receiving definitive radiotherapy in the era of risk stratification using smoking and human papillomavirus status.
    Amsbaugh MJ; Yusuf M; Cash E; Silverman C; Potts K; Dunlap N
    Head Neck; 2018 Apr; 40(4):687-695. PubMed ID: 29356189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in survival outcome between oropharyngeal and oral cavity squamous cell carcinoma in relation to HPV status.
    Lai K; Killingsworth M; Matthews S; Caixeiro N; Evangelista C; Wu X; Wykes J; Samakeh A; Forstner D; Niles N; Hong A; Lee CS
    J Oral Pathol Med; 2017 Sep; 46(8):574-582. PubMed ID: 27935119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.
    De Herdt MJ; Willems SM; van der Steen B; Noorlag R; Verhoef EI; van Leenders GJ; van Es RJ; KoljenoviÄ S; Baatenburg de Jong RJ; Looijenga LH
    Oncotarget; 2016 Mar; 7(11):13167-81. PubMed ID: 26909606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oropharyngeal squamous cell carcinoma in the veteran population: Association with traditional carcinogen exposure and poor clinical outcomes.
    Sandulache VC; Hamblin J; Lai S; Pezzi T; Skinner HD; Khan NA; Dioun SM; Hartman C; Kramer J; Chiao E; Zhou X; Zevallos JP
    Head Neck; 2015 Sep; 37(9):1246-53. PubMed ID: 24801106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
    Doweck I; Robbins KT; Samant S; Vieira F
    World J Surg Oncol; 2008 Jan; 6():2. PubMed ID: 18194553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary Squamous Cell Carcinoma of the Oral Cavity after Nasopharyngeal Carcinoma.
    Dai L; Fang Q; Li P; Wu J; Zhang X
    Cancer Res Treat; 2020 Jan; 52(1):109-116. PubMed ID: 31163959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting swallow outcome following treatment for advanced oral and oropharyngeal malignancies.
    Kalavrezos N; Cotrufo S; Govender R; Rogers P; Pirgousis P; Balasundram S; Lalabekyan B; Liew C
    Head Neck; 2014 Jan; 36(1):47-54. PubMed ID: 23559533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of close resection margins on local recurrence and disease-specific survival in oral and oropharyngeal carcinoma.
    Wong LS; McMahon J; Devine J; McLellan D; Thompson E; Farrow A; Moos K; Ayoub A
    Br J Oral Maxillofac Surg; 2012 Mar; 50(2):102-8. PubMed ID: 21742422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.